Sun Yong, Wei Yan-Jun, Xing Ying
China-Japan Union Hospital of Jilin University, Changchun, China.
Medicine (Baltimore). 2019 Aug;98(34):e16920. doi: 10.1097/MD.0000000000016920.
Vascular cognitive impairment (VCI) is a common cause of dementia. Research suggests that hereditary factors (gene mutations) play an important role in the pathogenesis of VCI, and a mutation of the NOTCH3 locus is frequently identified in affected patients. Herein, we report the case of a patient with confirmed VCI associated with a NOTCH3 exon 33 gene mutation and review the relevant VCI literature.
A 48-year-old man presented to our neurology clinic with gradually progressive cognitive impairment.
Brain magnetic resonance imaging revealed multiple punctate hyperintensities in the patient's periventricular white matter. Genetic analysis showed a c.6744C > T, p. Ala2223Val substitution in exon 33 of the NOTCH3 gene. We diagnosed thepatient with VCI secondary to a NOTCH3 gene mutation.
Donepezil (5 mg) and memantine (5 mg) daily.
The patient showed symptom improvement at his 3-month and 6-month follow-up appointments.
This patient may have a new type of mutation that is different from the one seen in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, although it involves a NOTCH3 defect. We propose that the entire NOTCH3 gene should be sequenced in patients with suspected hereditary VCI. This practice could facilitate the discovery of newpathogenic mutations and diseases.
血管性认知障碍(VCI)是痴呆的常见病因。研究表明,遗传因素(基因突变)在VCI的发病机制中起重要作用,且在受影响患者中经常发现NOTCH3基因座的突变。在此,我们报告1例确诊为与NOTCH3外显子33基因突变相关的VCI患者,并复习相关的VCI文献。
一名48岁男性因逐渐进展的认知障碍就诊于我们的神经科门诊。
脑磁共振成像显示患者脑室周围白质有多个点状高信号。基因分析显示NOTCH3基因外显子33存在c.6744C>T、p.Ala2223Val替换。我们诊断该患者为NOTCH3基因突变继发的VCI。
每天服用多奈哌齐(5毫克)和美金刚(5毫克)。
患者在3个月和6个月的随访中症状有所改善。
该患者可能有不同于伴皮质下梗死和白质脑病的常染色体显性遗传性脑动脉病中所见的新型突变,尽管它涉及NOTCH3缺陷。我们建议对疑似遗传性VCI患者进行整个NOTCH3基因测序。这种做法有助于发现新的致病突变和疾病。